Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-01-31 @ 3:10 AM
Study NCT ID:
NCT05472857
Status:
RECRUITING
Last Update Posted:
2024-03-06
First Post:
2022-07-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
Sponsor:
Suzhou Immunofoco Biotechnology Co., Ltd
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Claudin 18.2 CAR-T | View |